As of 2024-12-12, the Relative Valuation of CorMedix Inc (CRMD) is (17.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.53 USD, the upside of CorMedix Inc based on Relative Valuation is -287.9%.
The range of the Relative Valuation is (11.33) - (17.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 23.6x | 22.2x |
| Forward P/E multiples | 14.9x - 25.2x | 24.9x |
| Fair Price | (11.33) - (17.98) | (17.91) |
| Upside | -218.9% - -288.7% | -287.9% |
| Date | P/E |
| 2024-12-06 | -12.49 |
| 2024-12-05 | -12.75 |
| 2024-12-04 | -12.73 |
| 2024-12-03 | -12.95 |
| 2024-12-02 | -13.02 |
| 2024-11-29 | -12.96 |
| 2024-11-27 | -13.12 |
| 2024-11-26 | -12.86 |
| 2024-11-25 | -13.08 |
| 2024-11-22 | -13.10 |
| 2024-11-21 | -13.58 |
| 2024-11-20 | -14.12 |
| 2024-11-19 | -14.56 |
| 2024-11-18 | -14.35 |
| 2024-11-15 | -13.58 |
| 2024-11-14 | -14.46 |
| 2024-11-13 | -14.92 |
| 2024-11-12 | -15.34 |
| 2024-11-11 | -15.83 |
| 2024-11-08 | -15.25 |
| 2024-11-07 | -13.98 |
| 2024-11-06 | -13.57 |
| 2024-11-05 | -13.35 |
| 2024-11-04 | -12.61 |
| 2024-11-01 | -13.14 |
| 2024-10-31 | -13.22 |
| 2024-10-30 | -13.21 |
| 2024-10-29 | -17.05 |
| 2024-10-28 | -17.87 |
| 2024-10-25 | -17.15 |
| 2024-10-24 | -16.40 |
| 2024-10-23 | -16.24 |
| 2024-10-22 | -15.83 |
| 2024-10-21 | -14.73 |
| 2024-10-18 | -14.48 |
| 2024-10-17 | -13.79 |
| 2024-10-16 | -13.74 |
| 2024-10-15 | -13.27 |
| 2024-10-14 | -13.23 |
| 2024-10-11 | -13.31 |
| 2024-10-10 | -12.79 |
| 2024-10-09 | -13.06 |
| 2024-10-08 | -12.71 |
| 2024-10-07 | -12.06 |
| 2024-10-04 | -11.70 |
| 2024-10-03 | -10.90 |
| 2024-10-02 | -10.87 |
| 2024-10-01 | -10.65 |
| 2024-09-30 | -10.62 |
| 2024-09-27 | -10.58 |